메뉴 건너뛰기




Volumn 82, Issue 969, 2006, Pages 417-424

Treatment of inflammatory myopathies

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ALUMINUM HYDROXIDE; AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ECULIZUMAB; ETANERCEPT; FLUDARABINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROBENECID; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; TRIMETHOPRIM; WARFARIN;

EID: 33746040482     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2005.038455     Document Type: Review
Times cited : (34)

References (100)
  • 1
    • 0032726578 scopus 로고    scopus 로고
    • Assessing patients with lupus: Towards a drug responder index
    • Isenberg DA, Ramsey-Goldman R. Assessing patients with lupus: towards a drug responder index. Rheumatology 1999;38:1045-9.
    • (1999) Rheumatology , vol.38 , pp. 1045-1049
    • Isenberg, D.A.1    Ramsey-Goldman, R.2
  • 2
    • 0036099873 scopus 로고    scopus 로고
    • Treatment of dermatomyositis and polymyositis
    • Choy EHS, Isenberg DA. Treatment of dermatomyositis and polymyositis. Rheumatology 2002;41:7-13.
    • (2002) Rheumatology , vol.41 , pp. 7-13
    • Choy, E.H.S.1    Isenberg, D.A.2
  • 3
    • 0141651951 scopus 로고    scopus 로고
    • Polymyositis and dermatomyositis
    • Dalakas M. Polymyositis and dermatomyositis. Lancet 2003;362:971-82.
    • (2003) Lancet , vol.362 , pp. 971-982
    • Dalakas, M.1
  • 4
    • 1542645069 scopus 로고    scopus 로고
    • Idiopathic inflammatory myopathies: A treatment update
    • Oddis C. Idiopathic inflammatory myopathies: a treatment update. Curr Rheumatol Rep 2003;5:431-6.
    • (2003) Curr Rheumatol Rep , vol.5 , pp. 431-436
    • Oddis, C.1
  • 5
    • 0037381381 scopus 로고    scopus 로고
    • Inflammatory myopathies: Clinical, diagnostic and therapeutic aspects
    • Mastaglia F, Garlepp M, Phillips B, et al. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects. Muscle Nerve 2003;27:407-25.
    • (2003) Muscle Nerve , vol.27 , pp. 407-425
    • Mastaglia, F.1    Garlepp, M.2    Phillips, B.3
  • 6
    • 0142042344 scopus 로고    scopus 로고
    • Treatment of idiopathic inflammatory myopathies
    • Amato AA, Grigs RC. Treatment of idiopathic inflammatory myopathies. Curr Opin Neurol 2003;16:569-75.
    • (2003) Curr Opin Neurol , vol.16 , pp. 569-575
    • Amato, A.A.1    Grigs, R.C.2
  • 7
    • 0242500243 scopus 로고    scopus 로고
    • Presentation and management of idiopathic inflammatory muscle disease: Four case reports and commentary from a series of 78 patients
    • Kiely P, Heron C, Bruckner F. Presentation and management of idiopathic inflammatory muscle disease: four case reports and commentary from a series of 78 patients. Rheumatology 2003;42:575-82.
    • (2003) Rheumatology , vol.42 , pp. 575-582
    • Kiely, P.1    Heron, C.2    Bruckner, F.3
  • 8
    • 0037212819 scopus 로고    scopus 로고
    • Inflammatory myopathies: How to treat the difficult cases
    • Mastaglia F, Zilko P. Inflammatory myopathies: how to treat the difficult cases. Journal of Clinical Neuroscience 2003;10:99-101.
    • (2003) Journal of Clinical Neuroscience , vol.10 , pp. 99-101
    • Mastaglia, F.1    Zilko, P.2
  • 9
    • 0036172213 scopus 로고    scopus 로고
    • Results and long-term follow-up of intravenous immunoglobulin infusions in chronic, refractory polymyositis
    • Cherin P, Pelletier S, Teixeira A, et al. Results and long-term follow-up of intravenous immunoglobulin infusions in chronic, refractory polymyositis. Arthritis Rheum 2002;46:467-74.
    • (2002) Arthritis Rheum , vol.46 , pp. 467-474
    • Cherin, P.1    Pelletier, S.2    Teixeira, A.3
  • 10
    • 0035179180 scopus 로고    scopus 로고
    • Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies
    • Miller FW, Rider LG, Chung Y-L, for the International Myositis Outcome Assessment Collaborative Study Group, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology 2001;40:1262-73.
    • (2001) Rheumatology , vol.40 , pp. 1262-1273
    • Miller, F.W.1    Rider, L.G.2    Chung, Y.-L.3
  • 11
    • 9144261114 scopus 로고    scopus 로고
    • International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease
    • Isenberg DA, Allen E, Farewell V, for the International Myositis and Clinical Studies Group (IMACS), et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology 2004;43:49-54.
    • (2004) Rheumatology , vol.43 , pp. 49-54
    • Isenberg, D.A.1    Allen, E.2    Farewell, V.3
  • 12
    • 0000879831 scopus 로고    scopus 로고
    • Relationships among laboratory tests and global disease activity assessments in juvenile dermatomyositis
    • Rider L, Prasad K, Feldman B et al, for the JDM Disease Activity Collaborative Study Group. Relationships among laboratory tests and global disease activity assessments in juvenile dermatomyositis. Arthritis Rheum 1996;39(suppl):S191.
    • (1996) Arthritis Rheum , vol.39 , Issue.SUPPL.
    • Rider, L.1    Prasad, K.2    Feldman, B.3
  • 13
    • 0028817374 scopus 로고
    • Laboratory evaluation of the inflammatory myopathies
    • Rider LG, Miller FW. Laboratory evaluation of the inflammatory myopathies. Clin Diag Lab Immuol 1995;2:1-9.
    • (1995) Clin Diag Lab Immuol , vol.2 , pp. 1-9
    • Rider, L.G.1    Miller, F.W.2
  • 14
    • 0028327266 scopus 로고
    • Monitoring disease activity in juvenile dermatomyositis: The role of von Willebrand factor and muscle enzymes
    • Guzman J, Petty RE, Malleson PN. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes. J Rheumatol 1994;21:739-43.
    • (1994) J Rheumatol , vol.21 , pp. 739-743
    • Guzman, J.1    Petty, R.E.2    Malleson, P.N.3
  • 16
    • 0036165572 scopus 로고    scopus 로고
    • Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome
    • Schneider C, Gold R, Schäfers M, et al. Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome. Muscle Nerve 2002;25:286-8.
    • (2002) Muscle Nerve , vol.25 , pp. 286-288
    • Schneider, C.1    Gold, R.2    Schäfers, M.3
  • 17
    • 0033959857 scopus 로고    scopus 로고
    • Dermatomyositis
    • Callen JP. Dermatomyositis. Lancet 2000;355:53-7.
    • (2000) Lancet , vol.355 , pp. 53-57
    • Callen, J.P.1
  • 18
    • 0030681410 scopus 로고    scopus 로고
    • Clinical features of lupus myositis versus idiopathic myositis: A review of 30 cases
    • Garton MJ, Isenberg DA. Clinical features of lupus myositis versus idiopathic myositis: a review of 30 cases. Br J Rheumatol 1997;36:1067-74.
    • (1997) Br J Rheumatol , vol.36 , pp. 1067-1074
    • Garton, M.J.1    Isenberg, D.A.2
  • 19
    • 0041842435 scopus 로고    scopus 로고
    • Therapeutic approaches in patients with inflammatory myopathies
    • Dalakas MC. Therapeutic approaches in patients with inflammatory myopathies. Semin Neurol 2003;23:199-206.
    • (2003) Semin Neurol , vol.23 , pp. 199-206
    • Dalakas, M.C.1
  • 20
    • 0036145064 scopus 로고    scopus 로고
    • Cyclosporine a and intravenous immunoglobulin treatment in polymyositis/dermatomyositis
    • Danieli M, Malcangi G, Palmieri C, et al. Cyclosporine A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis. Ann Rheum Dis 2002;61:37-41.
    • (2002) Ann Rheum Dis , vol.61 , pp. 37-41
    • Danieli, M.1    Malcangi, G.2    Palmieri, C.3
  • 21
    • 0034041008 scopus 로고    scopus 로고
    • Mycophenolate mofetil in treatment of severe skin manifestations of dermatomyositis: A series of 4 cases
    • Gelber A, Nousari H, Wigley F. Mycophenolate mofetil in treatment of severe skin manifestations of dermatomyositis: a series of 4 cases. J Rheumatol 2000;27:1542-5.
    • (2000) J Rheumatol , vol.27 , pp. 1542-1545
    • Gelber, A.1    Nousari, H.2    Wigley, F.3
  • 22
    • 0028116241 scopus 로고
    • Current treatment of the inflammatory myopathies
    • Dalakas MC. Current treatment of the inflammatory myopathies. Curr Opin Rheumatol 1994;6:595-601.
    • (1994) Curr Opin Rheumatol , vol.6 , pp. 595-601
    • Dalakas, M.C.1
  • 23
    • 0038646387 scopus 로고    scopus 로고
    • Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: Preliminary observations
    • Hengstman G, van der Hoogen F, Barrera P, et al. Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations. Eur Neurol 2003;50:10-15.
    • (2003) Eur Neurol , vol.50 , pp. 10-15
    • Hengstman, G.1    Van Der Hoogen, F.2    Barrera, P.3
  • 24
    • 0016782856 scopus 로고
    • Polymyositis: Its presentation, morbidity and mortality
    • DeVere R, Bradley WG. Polymyositis: its presentation, morbidity and mortality. Brain 1975;98:637-66.
    • (1975) Brain , vol.98 , pp. 637-666
    • Devere, R.1    Bradley, W.G.2
  • 25
    • 0021362990 scopus 로고
    • Management od polymyositis and dermatomyositis
    • Ansell BM. Management od polymyositis and dermatomyositis. Clin Rheum Dis 1984;10:205-13.
    • (1984) Clin Rheum Dis , vol.10 , pp. 205-213
    • Ansell, B.M.1
  • 27
    • 0017499877 scopus 로고
    • Survival in polymyositis: Corticosteroids and risk factors
    • Carpenter JR, Bunch TW, Engel AG, et al. Survival in polymyositis: corticosteroids and risk factors. J Rheumatol 1977;4:207-14.
    • (1977) J Rheumatol , vol.4 , pp. 207-214
    • Carpenter, J.R.1    Bunch, T.W.2    Engel, A.G.3
  • 28
    • 0030872207 scopus 로고    scopus 로고
    • Idiopathic inflammatory myopathies
    • Amato AA, Barohn RJ. Idiopathic inflammatory myopathies. Neurol Clin 1997;15:615-48.
    • (1997) Neurol Clin , vol.15 , pp. 615-648
    • Amato, A.A.1    Barohn, R.J.2
  • 29
    • 0027403610 scopus 로고
    • Drug therapy of the idiopathic inflammatory myopathies: Predictors of response to prednisolone, azalhioprine and methotrexate and a comparison of their efficacy
    • Joffe MM, Love LA, Leff RI, et al. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisolone, azalhioprine and methotrexate and a comparison of their efficacy. Am J Med 1993;94:379-87.
    • (1993) Am J Med , vol.94 , pp. 379-387
    • Joffe, M.M.1    Love, L.A.2    Leff, R.I.3
  • 30
    • 0032818984 scopus 로고    scopus 로고
    • Functional outcome of myositis patients can a low-dose glucocorticoid regimen achieve good functional results?
    • Nzeusseu A, Brion F, Lefebvre C, et al. Functional outcome of myositis patients can a low-dose glucocorticoid regimen achieve good functional results? Clin Exp Rheumatol 1999;17:441-6.
    • (1999) Clin Exp Rheumatol , vol.17 , pp. 441-446
    • Nzeusseu, A.1    Brion, F.2    Lefebvre, C.3
  • 31
    • 0030511865 scopus 로고    scopus 로고
    • Update on therapy for refractory dermatomyositis and polymyositis
    • Villalba L, Adams EM. Update on therapy for refractory dermatomyositis and polymyositis. Curr Opin Rheumatol 1996;8:544-51.
    • (1996) Curr Opin Rheumatol , vol.8 , pp. 544-551
    • Villalba, L.1    Adams, E.M.2
  • 32
    • 0027729296 scopus 로고
    • Sucessful treatment of refractory polymyositis with pulse intravenous cyclophosphamide and low-dose weekly oral methotrexate therapy
    • Hirano F, Tanaka H, Nomura y, et al. Sucessful treatment of refractory polymyositis with pulse intravenous cyclophosphamide and low-dose weekly oral methotrexate therapy. Intern Med 1993;32:749-52.
    • (1993) Intern Med , vol.32 , pp. 749-752
    • Hirano, F.1    Tanaka, H.2    Nomura, Y.3
  • 33
    • 0013163116 scopus 로고    scopus 로고
    • Immunotherapy in autoimmune neuromuscular disorders
    • Gold R, Dalakas M, Toyka K. Immunotherapy in autoimmune neuromuscular disorders. Lancet Neurology 2003;2:22-32.
    • (2003) Lancet Neurology , vol.2 , pp. 22-32
    • Gold, R.1    Dalakas, M.2    Toyka, K.3
  • 34
    • 0025747908 scopus 로고
    • Combined steroid, methotrexate, and chlorambucil therapy for steroid resistant dermatomyositis
    • Cagnoli M, marchesoni A, Tosi S. Combined steroid, methotrexate, and chlorambucil therapy for steroid resistant dermatomyositis. Clin Exp Rheumatol 1991;9:658-9.
    • (1991) Clin Exp Rheumatol , vol.9 , pp. 658-659
    • Cagnoli, M.1    Marchesoni, A.2    Tosi, S.3
  • 35
    • 0031019356 scopus 로고    scopus 로고
    • Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis
    • Kasteler JS, Callen JP. Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis. J Am Acad Dermatol 1997;36:67-71.
    • (1997) J Am Acad Dermatol , vol.36 , pp. 67-71
    • Kasteler, J.S.1    Callen, J.P.2
  • 37
    • 0016146134 scopus 로고
    • Polymyositis and dermatomyositis: Combined methotrexate and corticosteroid therapy
    • Metzger AL, Bohan A, Goldberg LS, et al. Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy. Ann Intern Med 1974;81:182-9.
    • (1974) Ann Intern Med , vol.81 , pp. 182-189
    • Metzger, A.L.1    Bohan, A.2    Goldberg, L.S.3
  • 38
    • 0031931357 scopus 로고    scopus 로고
    • Treatment of refractory myositis: A randomised crossover study of two new cytotoxic regimens
    • Villalba L, Hicks JE, Adams EM, et al. Treatment of refractory myositis: a randomised crossover study of two new cytotoxic regimens. Arthritis Rheum 1998;41:392-9.
    • (1998) Arthritis Rheum , vol.41 , pp. 392-399
    • Villalba, L.1    Hicks, J.E.2    Adams, E.M.3
  • 39
    • 0036197698 scopus 로고    scopus 로고
    • Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo
    • Badrising U, Maat-Schieman M, Ferrari M, et al. Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo. Ann Neurol 2002;51:369-72.
    • (2002) Ann Neurol , vol.51 , pp. 369-372
    • Badrising, U.1    Maat-Schieman, M.2    Ferrari, M.3
  • 40
    • 0018907021 scopus 로고
    • Azathiprine with prednisolone for polymyositis. A controlled, clinical trial
    • Bunch TW, Worthington JW, Combs JJ, et al. Azathiprine with prednisolone for polymyositis. A controlled, clinical trial. Ann Intern Med 1980;92:365-9.
    • (1980) Ann Intern Med , vol.92 , pp. 365-369
    • Bunch, T.W.1    Worthington, J.W.2    Combs, J.J.3
  • 41
    • 0019463140 scopus 로고
    • Prednisolone and azathioprine for polymyositis: Long-term follow-up
    • Bunch TW. Prednisolone and azathioprine for polymyositis: long-term follow-up. Arthritis Rheum 1981;24:45-8.
    • (1981) Arthritis Rheum , vol.24 , pp. 45-48
    • Bunch, T.W.1
  • 42
    • 0022338128 scopus 로고
    • Dermato/polymyositis and other connective tissue diseases: A review of 105 cases
    • Tymms KE, Webb J. Dermato/polymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol 1985;12:1140-8.
    • (1985) J Rheumatol , vol.12 , pp. 1140-1148
    • Tymms, K.E.1    Webb, J.2
  • 43
    • 0033935721 scopus 로고    scopus 로고
    • Cyclosporine a versus methotrexate in the treatment of polymyositis and dermatomyositis
    • Vencovsky J, Jarosova K, Machacek S, et al. Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol 2000;29:95-102.
    • (2000) Scand J Rheumatol , vol.29 , pp. 95-102
    • Vencovsky, J.1    Jarosova, K.2    Machacek, S.3
  • 44
    • 0031452021 scopus 로고    scopus 로고
    • Preliminary evidence for cyclosporin a as an alternative in the treatment of recalcitant juvenile rheumatoid arthrirtis and juvenile dermatomyositis
    • Reiff A, Rawlings DJ, Shaham B, et al. Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitant juvenile rheumatoid arthrirtis and juvenile dermatomyositis. J Rheumatol 1997;24:2436-43.
    • (1997) J Rheumatol , vol.24 , pp. 2436-2443
    • Reiff, A.1    Rawlings, D.J.2    Shaham, B.3
  • 45
    • 0031056273 scopus 로고    scopus 로고
    • Cyclosporin treatment for polymyositis/dermatomyositis: Is it possible to rescue the deteriorating cases with interstitial pneumonitis?
    • Maeda K, Kimura R, Komuta K, et al. Cyclosporin treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis? Scand J Rheumatol 1997;26:24-9.
    • (1997) Scand J Rheumatol , vol.26 , pp. 24-29
    • Maeda, K.1    Kimura, R.2    Komuta, K.3
  • 46
    • 0029046668 scopus 로고
    • Dermatomyositis: Remission induced with combined oral cyclosporin and high-dose intravenous immune globulin
    • Saaded C, Bridges W, Burwick F. Dermatomyositis: remission induced with combined oral cyclosporin and high-dose intravenous immune globulin. South Med J 1995;88:866-70.
    • (1995) South Med J , vol.88 , pp. 866-870
    • Saaded, C.1    Bridges, W.2    Burwick, F.3
  • 47
    • 0032932507 scopus 로고    scopus 로고
    • A pilot study: Use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures
    • Adams EM, Pucino F, Yarboro C, et al. A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures. J Rheumatol 1999;26:352-60.
    • (1999) J Rheumatol , vol.26 , pp. 352-360
    • Adams, E.M.1    Pucino, F.2    Yarboro, C.3
  • 48
    • 0026014468 scopus 로고
    • Cyclosporin in the management of polymyositis and dermatomyositis
    • Lueck CJ, Trend P, Swash M. Cyclosporin in the management of polymyositis and dermatomyositis. J Neurol Neurosurg Psychiatry 1991;54:1007-8.
    • (1991) J Neurol Neurosurg Psychiatry , vol.54 , pp. 1007-1008
    • Lueck, C.J.1    Trend, P.2    Swash, M.3
  • 49
    • 0025070093 scopus 로고
    • Clinical effects of cyclosporin in dermatomyositis
    • Casato M, Bonomo L, Caccavo D, et al. Clinical effects of cyclosporin in dermatomyositis. Clin Exp Dermatol 1990;15:121-3.
    • (1990) Clin Exp Dermatol , vol.15 , pp. 121-123
    • Casato, M.1    Bonomo, L.2    Caccavo, D.3
  • 51
    • 0038070226 scopus 로고    scopus 로고
    • Immunoglobulin for rheumatic diseases in the twenty-first century: Take it or leave it?
    • Braun-Moscovici Y, Furst D. Immunoglobulin for rheumatic diseases in the twenty-first century: take it or leave it? Curr Opin Rheumatol 2003;15:237-45.
    • (2003) Curr Opin Rheumatol , vol.15 , pp. 237-245
    • Braun-Moscovici, Y.1    Furst, D.2
  • 52
    • 0142186303 scopus 로고    scopus 로고
    • High-dose intravenous immunoglobulin in inflammatory myopathies: Experience based on controlled clinical trials
    • Dalakas MC. High-dose intravenous immunoglobulin in inflammatory myopathies: experience based on controlled clinical trials. Neurol Sci 2003;24(suppl 4):S256-9.
    • (2003) Neurol Sci , vol.24 , Issue.SUPPL. 4
    • Dalakas, M.C.1
  • 53
    • 0028221479 scopus 로고
    • Intravenous immunoglobulin as first line therapy in polymyositis and dermatomyositis: An open study in 11 adult patients
    • Cherin P, Piette JC, Wechsler B, et al. Intravenous immunoglobulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients. J Rheumatol 1994;21:1092-7.
    • (1994) J Rheumatol , vol.21 , pp. 1092-1097
    • Cherin, P.1    Piette, J.C.2    Wechsler, B.3
  • 54
    • 0027729939 scopus 로고
    • A controlled trial of high dose intravenous immune globulin, infusions as treatment for dermatomyositis
    • Dalakas MC, Illa I, Dambrosia JM, et al. A controlled trial of high dose intravenous immune globulin, infusions as treatment for dermatomyositis. N Engl J Med 1993;329:1993-2000.
    • (1993) N Engl J Med , vol.329 , pp. 1993-2000
    • Dalakas, M.C.1    Illa, I.2    Dambrosia, J.M.3
  • 55
    • 0028113940 scopus 로고
    • High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments
    • Basta M, Dalakas MC. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest 1994;94:1729-35.
    • (1994) J Clin Invest , vol.94 , pp. 1729-1735
    • Basta, M.1    Dalakas, M.C.2
  • 56
    • 33746102773 scopus 로고    scopus 로고
    • Treatment of interstitial lung disease due to polimyositis with a 6 month course of intravenous pulse cyclopnosphamide
    • Meyer O, Hayem G, Palazzo E, et al. Treatment of interstitial lung disease due to polimyositis with a 6 month course of intravenous pulse cyclopnosphamide. Arthritis Rheum 2003;48(suppl):S308.
    • (2003) Arthritis Rheum , vol.48 , Issue.SUPPL.
    • Meyer, O.1    Hayem, G.2    Palazzo, E.3
  • 57
    • 0024418611 scopus 로고
    • The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy
    • Cronin ME, Miller FW, Hicks JE, et al. The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy. J Rheumatol 1989;16:1225-8.
    • (1989) J Rheumatol , vol.16 , pp. 1225-1228
    • Cronin, M.E.1    Miller, F.W.2    Hicks, J.E.3
  • 58
    • 0026474806 scopus 로고
    • Treatment of idiopathic inflammatory myopathies with cyclophosphamide pulses: Clinical experience and a review of literature
    • De Vita S, Fossaluzza V. Treatment of idiopathic inflammatory myopathies with cyclophosphamide pulses: clinical experience and a review of literature. Acta Neurol Belg 1992;92:215-27.
    • (1992) Acta Neurol Belg , vol.92 , pp. 215-227
    • De Vita, S.1    Fossaluzza, V.2
  • 59
    • 0025336203 scopus 로고
    • Sucessful IV pulse cyclophosphamide in refractory PM in 3 patients with SLE
    • Kono DH, Klashman DJ, Gilbert RC. Sucessful IV pulse cyclophosphamide in refractory PM in 3 patients with SLE. J Rheumatol 1990;17:982-3.
    • (1990) J Rheumatol , vol.17 , pp. 982-983
    • Kono, D.H.1    Klashman, D.J.2    Gilbert, R.C.3
  • 60
    • 0024836054 scopus 로고
    • Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis
    • Al-Janadi M, Smith CD, Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Rheumatol 1989;16:1592-6.
    • (1989) J Rheumatol , vol.16 , pp. 1592-1596
    • Al-Janadi, M.1    Smith, C.D.2    Karsh, J.3
  • 61
    • 33644582412 scopus 로고    scopus 로고
    • Efficacy of tacrolimus ointment for the treatment of cutaneous manifestations of juvenile dermatomyositis
    • Nézondet-Chetailee A-L, Nigrovic PA, Woodward AL, et al. Efficacy of tacrolimus ointment for the treatment of cutaneous manifestations of juvenile dermatomyositis. Arthritis Rheum 2002;46(suppl):S306.
    • (2002) Arthritis Rheum , vol.46 , Issue.SUPPL.
    • Nézondet-Chetailee, A.-L.1    Nigrovic, P.A.2    Woodward, A.L.3
  • 62
    • 24944451628 scopus 로고    scopus 로고
    • Treatment of antisynthetase associated interstitial lung disease with tacrolimus in patients with idiopathic inflammatory myopathy
    • Wilkes M, Sereika S, Fertig N, et al. Treatment of antisynthetase associated interstitial lung disease with tacrolimus in patients with idiopathic inflammatory myopathy. Arthritis Rheum 2003;48(suppl):S434.
    • (2003) Arthritis Rheum , vol.48 , Issue.SUPPL.
    • Wilkes, M.1    Sereika, S.2    Fertig, N.3
  • 63
    • 0033594767 scopus 로고    scopus 로고
    • Tacrolimus in refractory polymyositis with interstitial lung disease
    • Oddis CV, Sciurba F, Elmagd K, et al. Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 1999;353:1762.
    • (1999) Lancet , vol.353 , pp. 1762
    • Oddis, C.V.1    Sciurba, F.2    Elmagd, K.3
  • 64
    • 0037364125 scopus 로고    scopus 로고
    • Successful treatment of amyopathic dermatomyositis with topical tacrolimus
    • Ueda M, Makinodan R, Matsmura M, et al. Successful treatment of amyopathic dermatomyositis with topical tacrolimus. Br J Dermatol 2003;148:595-6.
    • (2003) Br J Dermatol , vol.148 , pp. 595-596
    • Ueda, M.1    Makinodan, R.2    Matsmura, M.3
  • 65
    • 0035830428 scopus 로고    scopus 로고
    • Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases
    • Chaudhry V, Cornblath DR, Griffin JW, et al. Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology 2001;56:94-6.
    • (2001) Neurology , vol.56 , pp. 94-96
    • Chaudhry, V.1    Cornblath, D.R.2    Griffin, J.W.3
  • 66
    • 14944368245 scopus 로고    scopus 로고
    • Mycophenolate mofetil (CellCept): An alternative therapy for autoimmune inflammatory myopathy
    • Majithia V, Harisdangkul V. Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy. Rheumatology 2005;44:386-9.
    • (2005) Rheumatology , vol.44 , pp. 386-389
    • Majithia, V.1    Harisdangkul, V.2
  • 67
    • 0027419766 scopus 로고
    • Chlorambucil: An effective corticosteroid-sparing agent for patients with recalcitrant dermatomyositis
    • Sinoway PA, Callen JP. Chlorambucil: an effective corticosteroid-sparing agent for patients with recalcitrant dermatomyositis. Arthritis Rheum 1993;36:319-24.
    • (1993) Arthritis Rheum , vol.36 , pp. 319-324
    • Sinoway, P.A.1    Callen, J.P.2
  • 68
    • 0022000202 scopus 로고
    • Combination immunosuppressive treatment of steroid-resistant dermatomyisitis/polymyositis
    • Wallace DJ, Metzger AL, White KK. Combination immunosuppressive treatment of steroid-resistant dermatomyisitis/polymyositis. Arthritis Rheum 1985;28:590-2.
    • (1985) Arthritis Rheum , vol.28 , pp. 590-592
    • Wallace, D.J.1    Metzger, A.L.2    White, K.K.3
  • 69
    • 0035990789 scopus 로고    scopus 로고
    • Dermatomyositis: An overview of recent progress with emphasis on dermatologic aspects
    • Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermat Clin 2002;20:387-408.
    • (2002) Dermat Clin , vol.20 , pp. 387-408
    • Sontheimer, R.D.1
  • 70
    • 0038437971 scopus 로고    scopus 로고
    • Use of etanercept in chronic juvenile dermatomyositis
    • Miller M, Smith R, Abbott K, et al. Use of etanercept in chronic juvenile dermatomyositis. Arthritis Rheum 2002;46(suppl):S306.
    • (2002) Arthritis Rheum , vol.46 , Issue.SUPPL.
    • Miller, M.1    Smith, R.2    Abbott, K.3
  • 71
    • 0035093233 scopus 로고    scopus 로고
    • Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes
    • Edwards JCW, Cambridge G. Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology 2001;40:205-11.
    • (2001) Rheumatology , vol.40 , pp. 205-211
    • Edwards, J.C.W.1    Cambridge, G.2
  • 72
    • 0033549067 scopus 로고    scopus 로고
    • IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using rituximab
    • Levine TD, Pestronk A. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using rituximab. Neurology 1999;52:1701-4.
    • (1999) Neurology , vol.52 , pp. 1701-1704
    • Levine, T.D.1    Pestronk, A.2
  • 73
    • 0036822286 scopus 로고    scopus 로고
    • An open study of b lymphocyte depletion in systemic lupus erythematosus
    • Leandro MJ, Edwards JC, Cambridge G, et al. An open study of b lymphocyte depletion in systemic lupus erythematosus. Arthritis Rheum 2002;46:2673-7.
    • (2002) Arthritis Rheum , vol.46 , pp. 2673-2677
    • Leandro, M.J.1    Edwards, J.C.2    Cambridge, G.3
  • 74
    • 13444278506 scopus 로고    scopus 로고
    • Rituximab in the treatment of dermatomyositis-an open label pilot study
    • Levine T. Rituximab in the treatment of dermatomyositis-an open label pilot study. Arthritis Rheum 2005;52:601-7.
    • (2005) Arthritis Rheum , vol.52 , pp. 601-607
    • Levine, T.1
  • 75
    • 0037710233 scopus 로고    scopus 로고
    • A pilot study of eculizumab in patients with dermatomyositis
    • Takada K, Bookbinder S, Furie R, et al. A pilot study of eculizumab in patients with dermatomyositis. Arthritis Rheum 2002;46(suppl):S489.
    • (2002) Arthritis Rheum , vol.46 , Issue.SUPPL.
    • Takada, K.1    Bookbinder, S.2    Furie, R.3
  • 76
    • 0038458498 scopus 로고    scopus 로고
    • Anti-T-lymphocyte globulin treatment in inclusion body myositis-a randomised pilot study
    • Lindberg C, Trysberg E, Tarkowski A, et al. Anti-T-lymphocyte globulin treatment in inclusion body myositis-a randomised pilot study. Neurology 2003;61:260-2.
    • (2003) Neurology , vol.61 , pp. 260-262
    • Lindberg, C.1    Trysberg, E.2    Tarkowski, A.3
  • 77
    • 0036835855 scopus 로고    scopus 로고
    • Severe dermatomyositis with rabdomyolisis and paralytic ileus: A case successful treated with plasmapheresis and intravenous immunoglobulin
    • Fukunaga E, Kunishige M, Mitsui T, et al. Severe dermatomyositis with rabdomyolisis and paralytic ileus: a case successful treated with plasmapheresis and intravenous immunoglobulin. Eur J Neurol 2002;9:697-8.
    • (2002) Eur J Neurol , vol.9 , pp. 697-698
    • Fukunaga, E.1    Kunishige, M.2    Mitsui, T.3
  • 78
    • 0026598194 scopus 로고
    • Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis
    • Miller FW, Leitman SF, Cronin ME, et al. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 1992;326:1380-4.
    • (1992) N Engl J Med , vol.326 , pp. 1380-1384
    • Miller, F.W.1    Leitman, S.F.2    Cronin, M.E.3
  • 79
    • 0026772754 scopus 로고
    • The association of plasma exchange synchronized with intravenous gamma globulin therapy in severe intractable polymyositis
    • Herson S, Cherin P, Coutellier A. The association of plasma exchange synchronized with intravenous gamma globulin therapy in severe intractable polymyositis. J Rheumatol 1992;19:828-9.
    • (1992) J Rheumatol , vol.19 , pp. 828-829
    • Herson, S.1    Cherin, P.2    Coutellier, A.3
  • 80
    • 0028968507 scopus 로고
    • Plasma exchange in polymyositis and dermatomyositis: A multicenter study of 57 cases
    • Cherin P, Auperin I, Bussel A, et al. Plasma exchange in polymyositis and dermatomyositis: a multicenter study of 57 cases. Clin Exp Rheumatol 1995;13:270-1.
    • (1995) Clin Exp Rheumatol , vol.13 , pp. 270-271
    • Cherin, P.1    Auperin, I.2    Bussel, A.3
  • 81
    • 13344269756 scopus 로고    scopus 로고
    • Autologous hematopoietic stem cells (hsc) transplantation in auto-immune disease: Extended results from French multicenter phasel-II study
    • Farge D, Marjanovic Z, Henegar C, et al. Autologous hematopoietic stem cells (hsc) transplantation in auto-immune disease: extended results from French multicenter phasel-II study. Arthritis Rheum 2003;48(suppl):S563.
    • (2003) Arthritis Rheum , vol.48 , Issue.SUPPL.
    • Farge, D.1    Marjanovic, Z.2    Henegar, C.3
  • 82
    • 0019885782 scopus 로고
    • Polymyositis, remarkable response to total body irradiation
    • Engel WK, Lighter AS, Galdi AP. Polymyositis, remarkable response to total body irradiation. Lancet 1981;i:658.
    • (1981) Lancet , vol.1 , pp. 658
    • Engel, W.K.1    Lighter, A.S.2    Galdi, A.P.3
  • 83
    • 0023838673 scopus 로고
    • Response to total body irradiation in dermatomyositis
    • Kelly JJ, Madoc-Jones H, Adelman LS, et al. Response to total body irradiation in dermatomyositis. Muscle Nerve 1988;11:120-3.
    • (1988) Muscle Nerve , vol.11 , pp. 120-123
    • Kelly, J.J.1    Madoc-Jones, H.2    Adelman, L.S.3
  • 84
    • 0021795470 scopus 로고
    • Total body irradiation and the cause of polymyositis
    • Morgan SH, Bernstein RM, Coppen J, et al. Total body irradiation and the cause of polymyositis. Arthritis Rheum 1985;28:831-5.
    • (1985) Arthritis Rheum , vol.28 , pp. 831-835
    • Morgan, S.H.1    Bernstein, R.M.2    Coppen, J.3
  • 85
    • 0343989909 scopus 로고
    • Total body irradiation in the treatment of intractable polymyositis and dermatomyositis
    • Dalakas MC, ed. Stoneham: Butterworth
    • Dalakas MC, Engel WK. Total body irradiation in the treatment of intractable polymyositis and dermatomyositis. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Stoneham: Butterworth, 1988:281-91.
    • (1988) Polymyositis and Dermatomyositis , pp. 281-291
    • Dalakas, M.C.1    Engel, W.K.2
  • 86
    • 24244474822 scopus 로고    scopus 로고
    • Benefits of exercise in the management of juvenile dermatomyositis-a new approach to physiotherapy
    • Maillard S, Jones R, Owens C, et al. Benefits of exercise in the management of juvenile dermatomyositis-a new approach to physiotherapy. Arthritis Rheum 2003;48(suppl):S433.
    • (2003) Arthritis Rheum , vol.48 , Issue.SUPPL.
    • Maillard, S.1    Jones, R.2    Owens, C.3
  • 87
    • 33746057093 scopus 로고    scopus 로고
    • Improved muscle function and altered muscle quality in myositis patients following physical exercise program
    • Dastmalchi M, Esbjornsson-Liljedahl M, Alexanderson H, et al. Improved muscle function and altered muscle quality in myositis patients following physical exercise program. Arthritis Rheum 2003;48(suppl):S312.
    • (2003) Arthritis Rheum , vol.48 , Issue.SUPPL.
    • Dastmalchi, M.1    Esbjornsson-Liljedahl, M.2    Alexanderson, H.3
  • 88
    • 33746085478 scopus 로고    scopus 로고
    • Immunosupprpressive agents for the treatment of interstitial pneumonitis associated with amyopathic dermatomyositis and polymyositis: Prognostic factors of the clinical outcome
    • Azuma K, Yamasaki Y, Ogawa H, et al. Immunosupprpressive agents for the treatment of interstitial pneumonitis associated with amyopathic dermatomyositis and polymyositis: prognostic factors of the clinical outcome. Arthritis Rheum 2003;48(suppl):S310.
    • (2003) Arthritis Rheum , vol.48 , Issue.SUPPL.
    • Azuma, K.1    Yamasaki, Y.2    Ogawa, H.3
  • 89
    • 0033840585 scopus 로고    scopus 로고
    • Effective treatment of Jo-1 associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation
    • Baron F, Ribbens C, Kaye O, et al. Effective treatment of Jo-1 associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. Br J Haematol 2000;110:339-42.
    • (2000) Br J Haematol , vol.110 , pp. 339-342
    • Baron, F.1    Ribbens, C.2    Kaye, O.3
  • 90
    • 0034990782 scopus 로고    scopus 로고
    • Autologous stem cell transplantation for rapidly progressive Jo-1-positive polymyositis and longterm follow-up
    • Bingham S, Griffiths B, McGonagle D, et al. Autologous stem cell transplantation for rapidly progressive Jo-1-positive polymyositis and longterm follow-up. Br J Haematol 2001;113:840-1.
    • (2001) Br J Haematol , vol.113 , pp. 840-841
    • Bingham, S.1    Griffiths, B.2    McGonagle, D.3
  • 91
    • 0036267607 scopus 로고    scopus 로고
    • Cutaneous involvement of dermatomyositis can respond to dapsone therapy
    • Cohen J. Cutaneous involvement of dermatomyositis can respond to dapsone therapy. Int J Dermatol 2002;41:182-4.
    • (2002) Int J Dermatol , vol.41 , pp. 182-184
    • Cohen, J.1
  • 93
    • 0036159587 scopus 로고    scopus 로고
    • Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis
    • Yoshimasu T, Ohtani T, Sakamoto T, et al. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol 2002;12:50-2.
    • (2002) Eur J Dermatol , vol.12 , pp. 50-52
    • Yoshimasu, T.1    Ohtani, T.2    Sakamoto, T.3
  • 94
    • 0035039694 scopus 로고    scopus 로고
    • An extremely severe case of cutaneus calcinosis with juvenile dermatomyositis, and sucessful treatment with diltiazem
    • Ichiki Y, Akiyama T, Shimozawa N, et al. An extremely severe case of cutaneus calcinosis with juvenile dermatomyositis, and sucessful treatment with diltiazem. Br J Dermatol 2001;144:894-7.
    • (2001) Br J Dermatol , vol.144 , pp. 894-897
    • Ichiki, Y.1    Akiyama, T.2    Shimozawa, N.3
  • 95
    • 0001260369 scopus 로고
    • Intermitent high dose intravenous methylprednisolone (IV pulse) prevents calcinosis and shortens disease course in juvenile dermatomyositis (JDMS)
    • Abstract
    • Callen AM, Pachman LM, Hayford J, et al. Intermitent high dose intravenous methylprednisolone (IV pulse) prevents calcinosis and shortens disease course in juvenile dermatomyositis (JDMS). (Abstract). Arthritis Rheum 1994;37:R10.
    • (1994) Arthritis Rheum , vol.37
    • Callen, A.M.1    Pachman, L.M.2    Hayford, J.3
  • 96
    • 0034037646 scopus 로고    scopus 로고
    • Regression of calcinosis associated with adult dermatomyositis following diltiazem therapy
    • Vinen CS, Patel S, Bruckner FE. Regression of calcinosis associated with adult dermatomyositis following diltiazem therapy. Rheumatology 2000;39:333-4.
    • (2000) Rheumatology , vol.39 , pp. 333-334
    • Vinen, C.S.1    Patel, S.2    Bruckner, F.E.3
  • 97
    • 0035012217 scopus 로고    scopus 로고
    • New insight into calcinosis of juvenile dermatomyositis: A study of composition and treatment
    • Mukamel M, Horev G, Mimouni M. New insight into calcinosis of juvenile dermatomyositis: A study of composition and treatment. J Pediatr 2001;138:763-6.
    • (2001) J Pediatr , vol.138 , pp. 763-766
    • Mukamel, M.1    Horev, G.2    Mimouni, M.3
  • 98
    • 0035006861 scopus 로고    scopus 로고
    • Treatment of calcinosis in juvenile dermatomyositis with probenecid: The role of phosphorus metabolism in the development of calcifications
    • Harel L, Harel G, Konrenreich L, et al. Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications. J Rheumatol 2001;28:1129-32.
    • (2001) J Rheumatol , vol.28 , pp. 1129-1132
    • Harel, L.1    Harel, G.2    Konrenreich, L.3
  • 99
    • 25344434437 scopus 로고    scopus 로고
    • The treatment of persistent severe idiopathic inflammatory myositis (HM) with anti-TNFα therapy
    • Maillard S, Wilkinson N, Riley P, et al. The treatment of persistent severe idiopathic inflammatory myositis (HM) with anti-TNFα therapy. Arthritis Rheum 2002;46(suppl):S307.
    • (2002) Arthritis Rheum , vol.46 , Issue.SUPPL.
    • Maillard, S.1    Wilkinson, N.2    Riley, P.3
  • 100
    • 0032709515 scopus 로고    scopus 로고
    • Intravenous immunoglobulin as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis
    • Marie I, Hachulla E, Levesque H, et al. Intravenous immunoglobulin as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol 1999;26:2706-9.
    • (1999) J Rheumatol , vol.26 , pp. 2706-2709
    • Marie, I.1    Hachulla, E.2    Levesque, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.